
Skepticism to Standard of Care: The T-Cell Journey, ft. Dr. James Mulé
The ImmunoVerse™
00:00
Foundations of Early T‑Cell Therapies with IL‑2
Dr. Patrick Hwu asks about initial T‑cell therapies; Mulé explains mouse studies, IL‑2 cloning, and how IL‑2 enabled T‑cell expansion for therapy.
Transcript
Play full episode


